1 Min Read
March 3 (Reuters) - Peregrine Pharmaceuticals Inc
* As of feb 21 Ronin Capital Llc Reports 6.8 Pct Stake In Peregrine Pharmaceuticals Inc- SEC filing Source text for Eikon: [ID:bit.ly/2lyZfNi] Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.